Exelixis, Inc. (EXEL)
44.32
+1.75
(+4.11%)
USD |
NASDAQ |
Dec 19, 16:00
44.32
0.00 (0.00%)
After-Hours: 20:00
Exelixis Shareholders Equity (Annual): 2.244B for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 538.55M |
| ADMA Biologics, Inc. | 349.02M |
| Aldeyra Therapeutics, Inc. | 71.00M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| Axsome Therapeutics, Inc. | 57.02M |